Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2017

Pharma News, 2017

Teva gets warning on its API China manufacturing facility
Teva gets warning on its API China manufacturing facility
Israel’s Teva Pharmaceutical Industries (NYSE.
Recordati establishes Canadian presence with launch of Recordati Rare Diseases Canada Inc.
Recordati establishes Canadian presence with launch of Recordati Rare Diseases Canada Inc.
TORONTO, April 13, 2017 /CNW/ - Recordati, a global biopharmaceutical company committed to providing orphan therapies to underserved rare disease communities, today announced the incorporation of its ...
Bristol-Myers to license two drugs to Biogen, Roche
Bristol-Myers to license two drugs to Biogen, Roche
Bristol-Myers Squibb Co said on Thursday it would license two of its drugs to Biogen Inc and Roche Holding AG for an upfront fee of $470 million.
When do pharmas disclose launch prices up front? When they’re pricing at a discount
When do pharmas disclose launch prices up front? When they’re pricing at a discount
Take a look at this year’s new drug approval announcements, and you may notice a pattern emerging among the companies willing to trumpet their pricing on approval day and those that make the market ...
This asthma drug can treat skin disorder
This asthma drug can treat skin disorder
London.
Vaccine to get rid of acne comes closer to reality
Vaccine to get rid of acne comes closer to reality
London.
Apple is reportedly working on sensors for diabetes treatment
Apple is reportedly working on sensors for diabetes treatment
Apple is quietly developing sensors that can track the body’s blood sugar levels in a bid to help people with diabetes, CNBC reports.
FDA warns Mylan over quality concerns at India facility
FDA warns Mylan over quality concerns at India facility
The U.
Antiparasitic drug may be new treatment for brain tumors
Antiparasitic drug may be new treatment for brain tumors
April 11 (UPI) -- A new study shows that a common antiparasitic medication could be effective at treating certain brain cancers including low-grade glioma.
FDA approves first drug to treat tardive dyskinesia
FDA approves first drug to treat tardive dyskinesia
The U.
Medivir Announces Positive Data From the Phase II Study of Remetinostat in Patients With Early-stage Cutaneous T-cell Lymphoma
Medivir Announces Positive Data From the Phase II Study of Remetinostat in Patients With Early-stage Cutaneous T-cell Lymphoma
STOCKHOLM, April 7, 2016 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm.
BerGenBio completes IPO, raising $49M for cancer trials
BerGenBio completes IPO, raising $49M for cancer trials
BerGenBio has completed (sub.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand